MAPT and supranuclear palsy, progressive, 1: There is currently limited research on how oligodendrocytes are involved in the pathogenesis of PSP and other tau-depositing disorders, even though the diversity of these inclusions is a major feature in the diagnosis and differentiation of these disorders [13].